MetaMolGen demonstrates enhanced molecular generation through meta-learning in drug discovery, suggesting efficient adaptation under low data conditions.
Molecular generation plays an important role in drug discovery and materials science, especially in data-scarce scenarios where traditional generative models often struggle to achieve satisfactory conditional generalization. To address this challenge, we propose MetaMolGen, a first-order meta-learning-based molecular generator designed for few-shot and property-conditioned molecular generation. MetaMolGen standardizes the distribution of graph motifs by mapping them to a normalized latent space, and employs a lightweight autoregressive sequence model to generate SMILES sequences that faithfully reflect the underlying molecular structure. In addition, it supports conditional generation of molecules with target properties through a learnable property projector integrated into the generative process.Experimental results demonstrate that MetaMolGen consistently generates valid and diverse SMILES sequences under low-data regimes, outperforming conventional baselines. This highlights its advantage in fast adaptation and efficient conditional generation for practical molecular design.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: